BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28186152)

  • 1. Association of polygenic risk for major psychiatric illness with subcortical volumes and white matter integrity in UK Biobank.
    Reus LM; Shen X; Gibson J; Wigmore E; Ligthart L; Adams MJ; Davies G; Cox SR; Hagenaars SP; Bastin ME; Deary IJ; Whalley HC; McIntosh AM
    Sci Rep; 2017 Feb; 7():42140. PubMed ID: 28186152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Whole-Genome and NETRIN1 Signaling Pathway-Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank.
    Barbu MC; Zeng Y; Shen X; Cox SR; Clarke TK; Gibson J; Adams MJ; Johnstone M; Haley CS; Lawrie SM; Deary IJ; ; ; McIntosh AM; Whalley HC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):91-100. PubMed ID: 30197049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia polygenic risk score influence on white matter microstructure.
    Simões B; Vassos E; Shergill S; McDonald C; Toulopoulou T; Kalidindi S; Kane F; Murray R; Bramon E; Ferreira H; Prata D
    J Psychiatr Res; 2020 Feb; 121():62-67. PubMed ID: 31770658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polygenic risk and white matter integrity in individuals at high risk of mood disorder.
    Whalley HC; Sprooten E; Hackett S; Hall L; Blackwood DH; Glahn DC; Bastin M; Hall J; Lawrie SM; Sussmann JE; McIntosh AM
    Biol Psychiatry; 2013 Aug; 74(4):280-6. PubMed ID: 23453289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiological Commonalities and Distinctions Among Three Major Psychiatric Diagnostic Categories: A Structural MRI Study.
    Chang M; Womer FY; Edmiston EK; Bai C; Zhou Q; Jiang X; Wei S; Wei Y; Ye Y; Huang H; He Y; Xu K; Tang Y; Wang F
    Schizophr Bull; 2018 Jan; 44(1):65-74. PubMed ID: 29036668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
    Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
    J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do substance use disorders compare to other psychiatric conditions on structural brain abnormalities? A cross-disorder meta-analytic comparison using the ENIGMA consortium findings.
    Navarri X; Afzali MH; Lavoie J; Sinha R; Stein DJ; Momenan R; Veltman DJ; Korucuoglu O; Sjoerds Z; van Holst RJ; Hester R; Orr C; Cousijn J; Yucel M; Lorenzetti V; Wiers R; Jahanshad N; Glahn DC; Thompson PM; Mackey S; Conrod PJ
    Hum Brain Mapp; 2022 Jan; 43(1):399-413. PubMed ID: 32643841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.
    Sewell MDE; Jiménez-Sánchez L; Shen X; Edmondson-Stait AJ; Green C; Adams MJ; Rifai OM; McIntosh AM; Lyall DM; Whalley HC; Lawrie SM
    Brain Behav Immun; 2021 Oct; 97():32-41. PubMed ID: 34107350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures.
    Harris MA; Shen X; Cox SR; Gibson J; Adams MJ; Clarke TK; Deary IJ; Lawrie SM; McIntosh AM; Whalley HC
    Psychol Med; 2020 Jul; 50(10):1653-1662. PubMed ID: 31317844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor analysis of lifetime psychopathology and its brain morphometric and genetic correlates in a transdiagnostic sample.
    Krug A; Stein F; David FS; Schmitt S; Brosch K; Pfarr JK; Ringwald KG; Meller T; Thomas-Odenthal F; Meinert S; Thiel K; Winter A; Waltemate L; Lemke H; Grotegerd D; Opel N; Repple J; Hahn T; Streit F; Witt SH; Rietschel M; Andlauer TFM; Nöthen MM; Philipsen A; Nenadić I; Dannlowski U; Kircher T; Forstner AJ
    Transl Psychiatry; 2024 Jun; 14(1):235. PubMed ID: 38830892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants.
    Ohi K; Nishizawa D; Shimada T; Kataoka Y; Hasegawa J; Shioiri T; Kawasaki Y; Hashimoto R; Ikeda K
    Int J Neuropsychopharmacol; 2020 Apr; 23(3):157-164. PubMed ID: 31900488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank.
    Leppert B; Millard LAC; Riglin L; Davey Smith G; Thapar A; Tilling K; Walton E; Stergiakouli E
    PLoS Genet; 2020 May; 16(5):e1008185. PubMed ID: 32392212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited Evidence for Association of Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes.
    Voineskos AN; Felsky D; Wheeler AL; Rotenberg DJ; Levesque M; Patel S; Szeszko PR; Kennedy JL; Lencz T; Malhotra AK
    Schizophr Bull; 2016 Jul; 42(4):1027-36. PubMed ID: 26712857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.
    Mullins N; Bigdeli TB; Børglum AD; Coleman JRI; Demontis D; Mehta D; Power RA; Ripke S; Stahl EA; Starnawska A; Anjorin A; ; Corvin A; Sanders AR; Forstner AJ; Reif A; Koller AC; Świątkowska B; Baune BT; Müller-Myhsok B; Penninx BWJH; Pato C; Zai C; Rujescu D; Hougaard DM; Quested D; Levinson DF; Binder EB; Byrne EM; Agerbo E; ; Streit F; Mayoral F; Bellivier F; Degenhardt F; Breen G; Morken G; Turecki G; Rouleau GA; Grabe HJ; Völzke H; Jones I; Giegling I; Agartz I; Melle I; Lawrence J; ; Walters JTR; Strohmaier J; Shi J; Hauser J; Biernacka JM; Vincent JB; Kelsoe J; Strauss JS; Lissowska J; Pimm J; ; Smoller JW; Guzman-Parra J; Berger K; Scott LJ; Jones LA; Azevedo MH; Trzaskowski M; Kogevinas M; Rietschel M; Boks M; Ising M; Grigoroiu-Serbanescu M; Hamshere ML; Leboyer M; Frye M; Nöthen MM; Alda M; Preisig M; Nordentoft M; Boehnke M; O'Donovan MC; Owen MJ; Pato MT; Renteria ME; Budde M; ; Weissman MM; Wray NR; Bass N; ; Craddock N; Smeland OB; Andreassen OA; Mors O; Gejman PV; Sklar P; McGrath P; Hoffmann P; McGuffin P; Lee PH; Mortensen PB; Kahn RS; Ophoff RA; Adolfsson R; Van der Auwera S; Djurovic S; Kloiber S; Heilmann-Heimbach S; Jamain S; Hamilton SP; McElroy SL; Lucae S; Cichon S; Schulze TG; Hansen T; Werge T; Air TM; Nimgaonkar V; Appadurai V; Cahn W; Milaneschi Y; ; ; ; Fanous AH; Kendler KS; McQuillin A; Lewis CM
    Am J Psychiatry; 2019 Aug; 176(8):651-660. PubMed ID: 31164008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits.
    Legge SE; Jones HJ; Kendall KM; Pardiñas AF; Menzies G; Bracher-Smith M; Escott-Price V; Rees E; Davis KAS; Hotopf M; Savage JE; Posthuma D; Holmans P; Kirov G; Owen MJ; O'Donovan MC; Zammit S; Walters JTR
    JAMA Psychiatry; 2019 Dec; 76(12):1256-1265. PubMed ID: 31553412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of major depressive disorder using polygenic risk scores for schizophrenia in two independent cohorts.
    Whalley HC; Adams MJ; Hall LS; Clarke TK; Fernandez-Pujals AM; Gibson J; Wigmore E; Hafferty J; Hagenaars SP; Davies G; Campbell A; Hayward C; Lawrie SM; Porteous DJ; Deary IJ; McIntosh AM
    Transl Psychiatry; 2016 Nov; 6(11):e938. PubMed ID: 27801894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiological substrates of major psychiatry disorders: transdiagnostic associations between white matter abnormalities, neuregulin 1 and clinical manifestation.
    Duan J; Wei Y; Womer FY; Zhang X; Chang M; Zhu Y; Liu Z; Li C; Yin Z; Zhang R; Sun J; Wang P; Wang S; Jiang X; Wei S; Zhang Y; Tang Y; Wang F
    J Psychiatry Neurosci; 2021 Sep; 46(5):E506-E515. PubMed ID: 34467747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connectome Disconnectivity and Cortical Gene Expression in Patients With Schizophrenia.
    Romme IA; de Reus MA; Ophoff RA; Kahn RS; van den Heuvel MP
    Biol Psychiatry; 2017 Mar; 81(6):495-502. PubMed ID: 27720199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of self-reported risk-taking behaviour, trans-ethnic consistency and relevance to brain gene expression.
    Strawbridge RJ; Ward J; Lyall LM; Tunbridge EM; Cullen B; Graham N; Ferguson A; Johnston KJA; Lyall DM; Mackay D; Cavanagh J; Howard DM; Adams MJ; Deary I; Escott-Price V; O'Donovan M; McIntosh AM; Bailey MES; Pell JP; Harrison PJ; Smith DJ
    Transl Psychiatry; 2018 Sep; 8(1):178. PubMed ID: 30181555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic risk for bipolar disorder and schizophrenia predicts structure and function of the ventromedial prefrontal cortex.
    Abé C; Petrovic P; Ossler W; Thompson WH; Liberg B; Song J; Bergen SE; Sellgren CM; Fransson P; Ingvar M; Landén M
    J Psychiatry Neurosci; 2021 Jul; 46(4):E441-E450. PubMed ID: 34291628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.